Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    21253697 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed The Effect of Glucagon-like-peptide 1 (GLP-1) Receptor Agonism on Diabetic Kidney Disease
Condition: Diabetic Kidney Disease
Intervention: Drug: Liraglutide

Indicates status has not been verified in more than two years